Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer

Radiotherapy and Oncology

Volumn 63, Issue 1, 2002, Pages 11-26

  Levegrün, Sabine ^a,b   Jackson, Andrew ^a   Zelefsky, Michael J ^a   Venkatraman, Ennapadam S ^a   Skwarchuk, Mark W ^a   Schlegel, Wolfgang ^b   Fuks, Zvi ^a   Leibel, Steven A ^a   Ling, C Clifton ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Biopsy; Conformal radiotherapy; Dose response; Model; Prostate cancer; Tumor control probability

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BEAM THERAPY; CANCER CENTER; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; HIGH RISK POPULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION RESPONSE; SCORING SYSTEM; TREATMENT OUTCOME; TUMOR BIOPSY;

BIOPSY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LOGISTIC MODELS; MALE; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK;

EID: 0036282882     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(02)00062-2     Document Type: Article

References (52)

1. Prostate
2. Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for malignant melanoma?
3. Dosimetric precision requirements in radiation therapy
4. Dose, volume, and tumour-control predictions in radiotherapy
5. Routine prostate biopsies following radiotherapy for prostate cancer: Results for 226 patients
6. Evaluation of radiation effect, tumor differentiation and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma
7. An approach to the interpretation of clinical data on the tumour control probability-dose relationship
8. Bootstrap methods: Another look at the jackknife
9. Predicting the radiation control probability of heterogeneous tumour ensembles: Data analysis and parameter estimation using a closed-form expression
10. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer
11. Histologic grading and clinical staging of prostatic adenocarcinoma
12. The probability of controlling an inhomogeneously irradiated tumor
13. Optimizing the radiation treatment and outcome of prostate cancer
14. Dose response observations for local control of adenocarcinoma of the prostate
15. The effect of dose on local control of prostate cancer
16. Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/mL
17. Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization and future directions
18. Dose selection for prostate cancer patients based on dose comparison and dose response studies
19. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model
20. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: Preliminary results of a phase I dose-escalation study
21. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: Interim report of a phase I dose-escalation study
22. The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate
23. Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose distribution variables and tumor control probability models
24. Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: Pitfalls in deducing radiobiologic parameters for tumors from clinical data
25. A comprehensive three-dimensional radiation treatment planning system
26. Maximizing local control by customized dose prescription for pelvic tumours
27. Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor
28. Radiation dose-response of human tumors
29. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer
30. Tumor radioresistance in clinical radiotherapy
31. Defining the appropriate radiaton dose for pretreatment PSA ≤10 ng/mL prostate cancer
32. External beam radiotherapy dose response of prostate cancer
33. Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer
34. Clinical implications of heterogeneity of tumor response to radiation therapy
35. A distribution-free procedure for comparing receiver operating characteristic curves from a paired experiment
36. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneuos distributions of dose and clonogenic cell density
37. Optimum parameters in a model for tumour control probability including interpatient heterogeneity
38. Tumor control probability of nasopharyngeal carcinoma: A comparison of different mathematical models
39. Inter-tumor heterogeneity and radiation dose-control curves
40. Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy
41. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma
42. The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy
43. Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: Reducing the potential morbidity of therapy
44. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
45. Three-dimensional conformal radiotherapy and dose escalation: Where do we stand?
46. Locally advanced prostate cancer: Long-term toxicity outcome after three-dimensional conformal radiotherapy - A dose escalation study
47. In response to Drs Vicini, Ziaja and Martinez
48. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer